Recombinant CD276 (Vobramitamab Biosimilar) antibody
This Humanized Chimeric antibody specifically detects CD276 (Vobramitamab Biosimilar) . It exhibits reactivity toward Human.
Catalog No. ABIN7598097
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant CD276 (Vobramitamab Biosimilar) antibody (ABIN7598097)
Target
CD276 (Vobramitamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Vobramitamab Biosimilar Antibody
-
Specificity
- CD276, B7-H3, Costimulatory molecule, B7H3, 4Ig-B7-H3, B7 homolog 3, CD276 antigen
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2.04 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- CD276 (Vobramitamab Biosimilar)
-
Alternative Name
- Vobramitamab Biosimilar
-
Target Type
- Biosimilar
-
Background
- CD276, B7-H3, Costimulatory molecule, B7H3, 4Ig-B7-H3, B7 homolog 3, CD276 antigen
-
UniProt
- Q5ZPR3
-
CAS-No
- 2490556-50-6
Target
-
You are here:
